Tyr Thr Gln - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

137061-48-4

腺苷酸环化酶激活肽-38(抗原)

H-HIS-SER-ASP-GLY-ILE-PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-AL;
H-HIS-SER-ASP-GLY-ILE-PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-Tyr-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2;
HIS-SER-ASP-GLY-ILE-PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-Tyr-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2;
HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2;
ADENYLATE CYCLASE ACTIVATING PEPTIDE-38;
ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38;
PACAP (1-38), AMIDE, HUMAN, OVINE, RAT;
PACAP (1-38), HUMAN, OVINE, RAT;
PACAP (1-38) (HUMAN, SHEEP, RAT)

无

HIS-ALA-ASP-ALA-VAL-PHE-Thr-ALA-ALA-Tyr-ALA-ARG-LEU-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-;
[ALA2,8,9,11,19,22,24,25,27,28]-VIP;
HIS-ALA-ASP-ALA-VAL-PHE-Thr-ALA-ALA-Tyr-ALA-ARG-LEU-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2

CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-Tyr

CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-Tyr;
FIBRONECTIN PRECURSOR (561-599), MOUSE, RAT;
FIBRONECTIN (530-568), BOVINE;
H-CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-Tyr-OH;
CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-Tyr;
CQDSETDTFY;
CQDSETRTFY;
COLLAGEN BINDING FRAGMENT;
CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-(CYS-Gln-ASP-SER-GLU-Thr-ARG-Thr-PHE-Tyr)

GLY-TRP-Thr-LEU-ASN-SER-ALA-GLY-Tyr-LEU-LEU-GLY-PRO-Gln-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-NH2;
GLY-TRP-Thr-LEU-ASN-SER-ALA-GLY-Tyr-LEU-LEU-GLY-PRO-Gln-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-NH2;
M617

VIP ANTAGONIST

H-LYS-PRO-ARG-ARG-PRO-Tyr-Thr-ASP-ASN-Tyr-Thr-ARG-LEU-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ASN-SE;
H-LYS-PRO-ARG-ARG-PRO-Tyr-Thr-ASP-ASN-Tyr-Thr-ARG-LEU-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ASN-SER-ILE-LEU-ASN-NH2;
KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2;
VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST;
VIP ANTAGONIST;
(lys1,pro2,5,arg3,4,Tyr6)-vasoactive*intestinal P;
(LYS1 PRO2 5 ARG3 4 Tyr6)-VASOACTIVE &;
(VIP-neurotensin) hybrid antagonist;
H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2

ARG-SER-ARG-Thr-ARG-Gln-PHE-Tyr-GLY-LEU-MET-NH2

H-ARG-SER-ARG-Thr-ARG-Gln-PHE-Tyr-GLY-LEU-MET-NH2;
HK-1, MOUSE;
HK-1 (MOUSE, RAT);
H-ARG-SER-ARG-Thr-ARG-Gln-PHE-Tyr-GLY-LEU-MET-NH2;
H2N-RSRTRQFYGLM-AMIDE;
HEMOKININ 1 (MOUSE);
HEMOKININ 1 (MOUSE, RAT);
HEK-1, MOUSE;
HEK-1 (MOUSE, RAT)

OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT)

PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-Gln-LYS-Thr-CYS-SER-CYS-ARG-LEU-Tyr-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-;
HYPOCRETIN;
PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-Gln-LYS-Thr-CYS-SER-CYS-ARG-LEU-Tyr-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-Thr-LEU-NH2;
PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-Gln-LYS-Thr-CYS-SER-CYS-ARG-LEU-Tyr-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-Thr-LEU-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14);
PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2;
PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2;
PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14);
OREXINS OREXIN A HUMAN, RAT, MOUSE;
OREXIN A, BOVINE, HUMAN, MOUSE, RAT

PACAP (6-38), HUMAN, OVINE, RAT

H-PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-AR;
FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2;
HIS-SER-ASP-GLY-ILE-PHE-Thr-AP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-Tyr-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2;
H-PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-Tyr-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2;
PHE-Thr-ASP-SER-Tyr-SER-ARG-Tyr-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-Tyr-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-Tyr-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2;
PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT);
PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT;
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT);
PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT)

PP60 C-SRC (521-533) (PHOSPHORYLATED)

H-Thr-SER-Thr-GLU-PRO-Gln-Tyr(PO3H2)-Gln-PRO-GLY-GLU-ASN-LEU-OH;
SRC PEPTIDE 521-533, PHOSPHORYLATED;
Thr-SER-Thr-GLU-PRO-Gln-PTyr-Gln-PRO-GLY-GLU-ASN-LEU;
Thr-SER-Thr-GLU-PRO-Gln-Tyr(PO3H2)-Gln-PRO-GLY-GLU-ASN-LEU;
PP 60C-SRC (521-533);
PP60 C-SRC (521-533) (PHOSPHORYLATED);
PP60C-SRC CARBOXY-TERMINAL PHOSPHOREGULATORY PEPTIDE, PHOSPHORYLATED;
PP60C-SRC C-TERMINAL PHOSPHOREGULATORY PEPTIDE;
PP60C-SRC FRAGMENT 521-533

Thr-PHE-Gln-ALA-Tyr-PRO-LEU-ARG-GLU-ALA: TFQAYPLREA;
Thr-PHE-Gln-ALA-Tyr-PRO-LEU-ARG-GLU-ALA: TFQAYPL

Thr-PHE-Gln-ALA-Tyr-PRO-LEU-ARG-GLU-ALA;
RETROVIRAL PROTEASE SUBSTRATE;
Thr-PHE-Gln-ALA-Tyr-PRO-LEU-ARG-GLU-ALA;
T-F-Q-A-Y-P-L-R-E-A;
H-Thr-PHE-Gln-ALA-Tyr-PRO-LEU-ARG-GLU-ALA-OH

CARCINOEMBRYONIC ANTIGEN (101-115);
H-Thr-GLY-Gln-PHE-ARG-VAL-Tyr-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE-OH;
CARCINOEMBRYONIC ANTIGEN (101-115);
CARCINOEMBRYONIC ANTIGEN FRAGMENT 101-115;
CEA (101-115);
Thr-GLY-Gln-PHE-ARG-VAL-Tyr-PRO-GLU-LEU-PRO-LYS-PRO-SER-ILE;
CARCINOEMBRYONIC ANTIGEN FRAGMENT 101- &

Tyr-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-Tyr-Tyr-SER-ALA-LEU-ARG-

H-ALA-ARG-Tyr-Tyr-SER-ALA-LEU-ARG-HIS-Tyr-ILE-ASN-LEU-ILE-Thr-ARG-Gln-ARG-Tyr-NH2;
ALA-ARG-Tyr-Tyr-SER-ALA-LEU-ARG-HIS-Tyr-ILE-ASN-LEU-ILE-Thr-ARG-Gln-ARG-Tyr-NH2;
ARYYSALRHYINLITRQRY-NH2;
H-ALA-ARG-Tyr-Tyr-SER-ALA-LEU-ARG-HIS-Tyr-ILE-ASN-LEU-ILE-Thr-ARG-Gln-ARG-Tyr-NH2;
NEUROPEPTIDE Y (18-36);
NEUROPEPTIDE Y(18-36), PORCINE;
NEUROPEPTIDE Y FRAGMENT 18-36 HUMAN, PORCINE;
NPY (18-36);
NPY(18-36) PORCINE

C112H174N36O27

详情

供应商

化工产品